Doxil — The First FDA-Approved Nano-Drug: From an Idea to a Product - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 390

Forssen, E.A., and Tokes, Z.A., Improved therapeutic benefits of doxorubicin
by entrapment in anionic liposomes, Cancer Res ., 43 , 546-550 (1983).
Gabizon, A., Amselem, S., Goren, D., Cohen, R., Druckmann, S., Fromer, I.
Chisin, R. Peretz, T., Sulkes, A., and Barenholz, Y., Preclinical and clinical
experience with doxorubicin with a doxorubicin liposome preparation,
J. Liposome Res . 1 , 491-502 (1991b).
Gabizon, A.A., and Barenholz, Y., Adriamycin-containing liposomes in cancer
chemotherapy. In: Liposomes as Drug Carriers (Gregoriadis, G., ed.)
Wiley, New York, pp. 365-379 (1988).
Gabizon, A., and Barenholz, Y., Liposomal anthracyclines — from basics to
clinical approval of pegylated liposomal doxorubicin. In: Liposomes:
Rational Design (Janoff , A.S., ed.), Marcel Dekker, New York, pp. 343-
362 (1999).
Gabizon, A., and Barenholz, Y., A method for drug loading, WO 2005/046643
A2 (2005).
Gabizon, A.A., Barenholz, Y., and Bialer, M., Prolongation of the circulation time
of doxorubicin encapsulated in liposomes containing a polyethylene
glycol-derivatized phospholipid: pharmacokinetic studies in rodents
and dogs, Pharm. Res ., 10, 703-708 (1993).
Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F.,
Huang, A., and Barenholz, Y., Prolonged circulation time and enhanced
accumulation in malignant exudates of doxorubicin encapsulated
in polyethylene-glycol coated liposomes, Cancer Res. , 54 , 987-992
(1994).
Gabizon, A., Chisin, R. Amselem, S., Druckmann, S., Cohen, R., Goren, D.,
Fromer, I., Peretz, T., Sulkes, A., and Barenholz, Y., Pharmacokinetic
and imaging studies in patients receiving a formulation of liposome-
associated Adriamycin, Br. J. Cancer , 64 , 1125-1132 (1991a).
Gabizon, A., Dagan, A., Goren, D., Barenholz, Y., and Fuks, Z., Liposomes as
in vivo carriers of Adriamycin: reduced cardiac uptake and preserved
antitumor activity, Cancer Res . 42 , 4734-4739 (1982).
Gabizon, A., Goren, D., and Barenholz, Y., Investigation on the anti-tumor
efficacy of liposome associated doxorubicin in murine tumor models,
Isr. J. Med. Sci . 24 , 512-517 (1988).
Gabizon, A., Goren, D., Fuks, Z., Barenholz, Y., Dagan, A. and Meshorer, A.,
Enhancement of Adriamycin delivery to liver metastatic cells with
increased tumoricidal eff ect using liposomes as drug carriers, Cancer
Res . 43 , 4730-4735 (1983).
Gabizon, A., Goren, D., Fuks, Z., Meshorer, A., and Barenholz, Y., Superior
therapeutic activity liposome-associated Adriamycin in a murine
metastatic tumour model, Br. J. Cancer 51, 681-689 (1985).